文献速递主动脉疾病

肾功能不全患者胸主动脉及复杂主动脉腔内修复术的结局

Outcomes of Thoracic and Complex Endovascular Aortic Repair in Patients with Renal Insufficiency.
PubMed 文献 · Ann Vasc Surg · 2024-07-17

基于VQI-VISION数据库回顾性分析2010至2018年行TEVAR或cEVAR的4867例患者,比较无CKD或透析、CKD及透析三组结局。CKD患者院内MI风险约为无CKD或透析者的2倍,透析患者30天死亡风险更高,透析与CKD均与30天及1年死亡风险升高相关。

要点

  • CKD患者院内MI的OR为2.02,30天死亡OR为1.56。
  • 透析患者30天死亡OR为3.31,1年死亡HR为3.48。
  • 透析患者1年再干预HR为1.72,CKD患者1年死亡HR为1.45。

核心结论

  • 透析与CKD患者对比无CKD或透析者,院内卒中、SCI及1年动脉瘤破裂风险无显著差异。
  • CKD患者院内MI风险约为无CKD或透析者的2倍,透析患者1年再干预风险更高。
  • 透析与CKD患者30天及1年死亡风险均更高。

研究设计与样本

  • 利用VQI-VISION数据库回顾性评估2010至2018年行TEVAR或cEVAR的患者。
  • 共纳入4867例,无CKD或透析2694例,CKD 2047例,透析126例。
  • 院内结局采用多变量logistic回归分析,1年结局采用Kaplan-Meier生存分析与Cox回归分析。

主要发现

  • 透析患者显著更年轻,非白人及西班牙裔/拉丁裔比例更高,合并症更多。
  • CKD患者院内MI的OR为2.02(95%CI 1.43-2.86,P<0.001),30天死亡的OR为1.56(95%CI 1.18-2.07,P<0.001)。
  • 透析患者30天死亡的OR为3.31(95%CI 1.73-6.35,P<0.001)。
  • 1年时透析与死亡风险升高相关(HR 3.48,95%CI 2.39-5.07,P<0.001)及再干预风险升高相关(HR 1.72,95%CI 1.001-2.94,P<0.049)。
  • CKD与1年死亡风险升高相关(HR 1.45,95%CI 1.21-1.75,P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thoracic endovascular aortic repair (TEVAR) and complex endovascular aneurysm repair (cEVAR) are effective and minimally invasive treatment options for preventing rupture and decreasing mortality of aortic aneurysms. Patients with renal insufficiency are prone to worse postoperative cardiovascular morbidity and mortality due to the atherosclerosis burden as well as increased levels of angiotensin II. Nonetheless, knowledge about the outcomes of aortic stent graft therapy in patients with chronic kidney disease (CKD) or dialysis is scarce. This study aimed to examine outcomes after TEVAR and cEVAR in patients on CKD and dialysis. METHODS: Utilizing data from the Vascular Quality Initiative (VQI) Vascular Implant Surveillance and Interventional Outcomes Network database, we retrospectively evaluated patients who underwent TEVAR or cEVRA from 2010 to 2018. Patients were divided into patients with no CKD or dialysis, CKD patients, and dialysis patients. Outcomes were in-hospital stroke, myocardial infarction (MI), spinal cord ischemia (SCI), 30-day mortality, 1-year mortality, aneurysmal rupture, and reintervention. In-hospital outcomes were assessed using multivariable logistic regression analysis and 1-year outcomes were evaluated using Kaplan-Meier Survival and Cox regression analyses. RESULTS: A total of 4,867 patients were included in the study, 2,694 had no CKD or dialysis, 2,047 had CKD, and 126 were on dialysis. Dialysis patients were significantly younger, and more likely to be non-White and of Hispanic/Latino origin. They were also more likely to have medical comorbidities. CKD patients had higher odds of in-hospital MI (odds ratio [OR]: 2.02, 95% confidence interval [CI] (1.43-2.86), P < 0.001) and 30-day mortality (OR: 1.56, 95% CI (1.18-2.07), P < 0.001) compared to patients with no CKD or dialysis. Dialysis patients had higher odds of 30-day mortality (OR: 3.31, 95% CI (1.73-6.35), P < 0.001). At 1 year, dialysis was associated with a higher risk of mortality (hazard ratio [HR]: 3.48, 95% CI (2.39-5.07), P < 0.001) and reintervention (HR: 1.72, 95% CI (1.001-2.94), P < 0.049). CKD was associated with a higher risk of mortality (HR: 1.45, 95% CI (1.21-1.75), P < 0.001) compared to patients with no CKD or dialysis. CONCLUSIONS: Among patients undergoing TEVAR or cEVAR, there was no significant difference in the risk of in-hospital stroke, SCI, and 1-year aneurysmal rupture among dialysis and CKD patients compared to patients with no CKD or dialysis. However, CKD patients had twice the risk of in-hospital MI. Dialysis patients had a higher risk of 1-year reintervention. Both dialysis and CKD patients had a higher risk of 30-day and 1-year mortality.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Elsayed N, Perez S, Straus SL, et al. Outcomes of Thoracic and Complex Endovascular Aortic Repair in Patients with Renal Insufficiency. Ann Vasc Surg. 2024. PMID: 39029897. doi:10.1016/j.avsg.2024.06.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。